Analysis:
1) Target variable / resolution alignment  
This resolves to the **CDC-reported cumulative number of confirmed U.S. measles cases in 2026 (cases), as of April 24, 2026**, taken from the CDC “Measles Cases and Outbreaks” page in the **final update reflecting reports as of Thursday, April 30, 2026**.

(a) Source analysis (what each says, quality, date)
- CDC “Measles Cases and Outbreaks” (updated Feb 6, 2026; data as of Feb 5): **733 confirmed U.S. cases in 2026** (727 residents across 20 jurisdictions + 6 international visitors). Also: **92% outbreak-associated**, and most (662) linked to outbreaks that began in 2025. *Highest-quality, resolution-authoritative, directly on-criteria.*
- North Carolina DHHS outbreak page (as of Feb 10, 2026): NC has **18 cases since Dec 2025**, mostly pediatric and mostly unvaccinated/unknown. *High-quality for NC; indirect for national total.*
- UCLA Health explainer (Feb 9, 2026): repeats CDC 733 and gives context on drivers (declining vaccination, global circulation). *Good secondary source; mostly explanatory; not resolution authority.*
- USA Today graphic/story (Feb 10, 2026): cites CDC totals and highlights **South Carolina as epicenter** with **546 cases in 2026 as of Feb 5** (within a larger outbreak). Some internal wording appears error-prone but state figure aligns with the “SC is dominant share” narrative. *Medium-high quality; relies on CDC/state reporting; some editorial inconsistencies.*
- ABC News (Feb 2026): repeats CDC 733; includes expert commentary (Daskalakis) that defenses are down in low-coverage communities. *Good secondary; qualitative direction more than quantitative.*
- IDSE / PAHO warning (Feb 11, 2026): notes PAHO alert urging surveillance/vaccination; excerpt truncated. *Moderate; directionally relevant but not quantitative.*
- AskNews items (The Hill, Independent/AP writeups, U.S. News & World Report, etc., Jan–Feb 2026): generally consistent that 2025 was very high and 2026 is unusually high early; some claim “800+ cases by Feb 11” which may reflect **newer-than-Feb-5 counts**, non-CDC aggregation, or timing differences. *Mixed quality: AP/major outlets are solid for context; but for the actual count I anchor to CDC.*

(b) Evidence analysis (weighted)
Strong evidence (moves forecast meaningfully)
- **CDC: 733 cases by Feb 5** (very high early-year level; direct to resolution metric).
- **Outbreak structure: 92% outbreak-associated; 662 linked to 2025-origin outbreaks** → indicates ongoing chains rather than isolated imports (persistence risk into April).
- **Seasonality / timing**: late winter–spring is typically favorable for measles transmission in under-immunized networks; we are forecasting into that window.

Moderate evidence (moderate shifts)
- **Concentration in South Carolina (hundreds of cases early 2026)** suggests the national trajectory is dominated by whether one/few large outbreaks burn out vs. continue.
- **Vaccination coverage ~92.5% in kindergartners (below 95% herd threshold)**: structural, slow-moving risk factor; supports continued outbreaks and occasional new ones.
- **Large regional burden (Mexico thousands of cases; PAHO alerts)** increases importation pressure and cross-border re-seeding risk through April.

Weak evidence (small shifts)
- Claims of “800+” by Feb 11 in some articles without clear reconciliation to CDC’s timestamp; useful as a hint that counts may be rising quickly, but not trusted enough to re-anchor the baseline away from CDC Feb 5.

(c) Timeframe analysis
- Now (Feb 12, 2026) to target date (Apr 24, 2026): **71 days**, but operationally we’re projecting CDC cumulative count through Apr 24, captured on the **Apr 30** CDC update (so roughly **10–11 weeks of additional accrual** from early/mid-February).
- If timeframe were halved (~5 weeks), I’d expect totals clustered much closer to the current 733 baseline (roughly +200 to +800).  
- If timeframe were doubled (~20–22 weeks), tail risk rises a lot (more opportunities for new outbreaks), and I’d shift the upper percentiles substantially upward.

(d) Justification (inside-view adjustments to outside-view base rates)
Outside view baseline (given): P10 1250, P20 1450, P40 1700, P60 1950, P80 2350, P90 2750.

Inside-view changes:
- Upward pressure vs outside view: (i) the **very high early-year starting point (733 by Feb 5)**, (ii) **dominance of continuing 2025-origin outbreaks**, and (iii) **regional importation pressure (notably Mexico)** all increase the chance that April cumulative totals land above the 2025-like trajectory implied by the outside-view upper percentiles.
- Downward pressure: outbreak response (quarantine, targeted vaccination, school/community interventions) can **sharply reduce effective transmission** in a few generations; measles outbreaks can “burn out” once susceptible clusters are exhausted. This keeps the median from shifting dramatically upward.
- Net: I keep the center near ~1.8k–2.1k but **widen and raise the right tail** (higher 80th/90th), because the key uncertainty is whether additional large outbreaks ignite or the main outbreak persists through spring.

Distribution calibration:
- Simple continuation check: From Feb 5 to Apr 24 is ~78 days. If average net accrual were:
  - ~8/day → +624 → ~1350 total
  - ~12/day → +936 → ~1670 total
  - ~16/day → +1248 → ~1980 total
  - ~24/day → +1872 → ~2600 total
  - ~35/day → +2730 → ~3460 total  
Given seasonality and ongoing large outbreaks, I view ~12–20/day as the most likely band, with meaningful probability of ≥24/day if outbreaks expand.

Checklist:
1) Paraphrase: CDC-confirmed cumulative U.S. measles cases in 2026 (cases) as of Apr 24, recorded from CDC’s Apr 30 update.  
2) Outside view base rate distribution: 1250 / 1450 / 1700 / 1950 / 2350 / 2750.  
3) Consistency check: Implied median ≈ 1900–2000; mean ≈ 2200–2400 (right-skew). Yes—skew reflects outbreak tail risk.  
4) Key evidence (most significant):
   - CDC: 733 cases as of Feb 5 (very high early-year baseline).
   - 92% outbreak-associated; most cases tied to 2025-origin outbreaks (persistence risk).
   - Spring seasonality + below-threshold vaccination coverage (structural susceptibility).
   - South Carolina dominating early counts (trajectory hinges on whether it burns out).
   - Mexico/region experiencing very large outbreak (importation/reseeding pressure).
5) Blind spot: A rapid, coordinated vaccination/quarantine push that collapses major outbreaks faster than expected → outcome much lower.  
6) Status quo: Expect gradual decline in growth rate as big outbreaks exhaust susceptibles, but not guaranteed; keep center near outside view while widening upper tail.  
7) Technicalities: Percentiles strictly increasing; units are cases.

Percentile 10: 1200
Percentile 20: 1400
Percentile 40: 1750
Percentile 60: 2050
Percentile 80: 2800
Percentile 90: 3800